Drug intelligence / Profile preview

Tacrovin Forte

Development stage
Unknown
Lead developer
Galcare Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Tacrovin Forte is a topical dermatological medication containing 0.1% w/w tacrolimus, a small molecule immunosuppressant. Developed and marketed by Galcare Pharmaceutical, it is available in both ointment and lotion formulations. Tacrolimus acts as a calcineurin inhibitor, which prevents the activation of T-lymphocytes and the subsequent release of pro-inflammatory cytokines. It is primarily indicated for the treatment of moderate-to-severe atopic dermatitis (eczema) and vitiligo, particularly in patients who are unresponsive to or intolerant of conventional therapies like topical corticosteroids. Additionally, it is utilized for other inflammatory skin conditions such as psoriasis, lichen planus, contact dermatitis, and steroid-induced rosacea. The formulation is designed for external use and is suitable for application on widespread or hairy areas of the skin.

Brand names
Tacrovin Forte
Other names
Tacrovin Forte 0.1%
02

Targets

FKBP1ACN (Calcineurin)

Beyond the preview

Go deeper on Tacrovin Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tacrovin Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call